{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:19:14Z","timestamp":1794431954770,"version":"4.9.1"},"reference-count":51,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:sec id=\"ab-coi230066-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Management of colorectal cancer (CRC) has been updated continuously over the past 2 decades. While the combination of these initiatives has had implications for improved survival, the implications for rates of recurrence remain unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi230066-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To ascertain the rates of recurrence and describe time to recurrence within 5 years of surgery with curative intent for stages I to III CRC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi230066-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cohort study used the Danish Colorectal Cancer Group Database to identify patients with Union for International Cancer Control (UICC) stages I to III CRC who underwent primary surgery between January 1, 2004, and December 31, 2019. They were followed up until recurrence (event), death (competing event), diagnosis of a second cancer (competing event), emigration (censoring event), 5 years postoperatively (censoring event), or January 1, 2023 (censoring event), whichever came first. Recurrence status was ascertained through individual-level linked data from the Danish Cancer Registry, Danish National Patient Registry, and Danish Pathology Registry using a validated algorithm. Data were analyzed from January 1 to August 8, 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi230066-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Primary surgery performed during 3 calendar periods (2004-2008, 2009-2013, and 2014-2019) stratified by tumor site (colon or rectum) and UICC stage (I, II, and III).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi230066-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Stage-specific 5-year recurrence reported as the cumulative incidence function (CIF) of recurrence, the association between calendar period of primary surgery and recurrence risk reported as subdistribution hazard ratios (sHRs), and the time from surgery to recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi230066-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 34\u202f166 patients with UICC stages I to III CRC (median [IQR] age, 70 [62-77] years); 18 552 males [54.3%]) included in the study, 7027 developed recurrence within 5 years after the primary surgery. For colon cancer, the 5-year CIF of recurrence decreased over the 3 calendar periods from 16.3% to 6.8% for UICC stage I, from 21.9% to 11.6% for UICC stage II, and from 35.3% to 24.6% for UICC stage III colon cancer. For rectal cancer, the 5-year CIF decreased over the 3 periods from 19.9% to 9.5% for stage I, from 25.8% to 18.4% for stage II, and from 38.7% to 28.8% for stage III disease. Patients with stage III disease had a shorter time from surgery to recurrence compared with those with stage I disease (time ratio stage III vs stage I\u2009=\u20090.30; 95% CI, 0.28-0.32). Cancers detected through screening were associated with lower stage-adjusted risks of recurrence (sHR, 0.81; 95% CI, 0.73-0.91) compared with cancers not detected through screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-coi230066-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort of patients with CRC, the risk of recurrence decreased in patients with stages I to III disease during the study period. Cancer detection by screening was associated with an even lower risk of recurrence. Time to recurrence differed according to UICC stage. Because the risk of recurrence was so low in selected patient groups, future research is warranted to explore risk-stratified surveillance protocols in patients with CRC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaoncol.2023.5098","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T08:30:59Z","timestamp":1700123459000},"page":"54","source":"Crossref","is-referenced-by-count":171,"title":["Incidence of Recurrence and Time to Recurrence in Stage I to III Colorectal Cancer"],"prefix":"10.1001","volume":"10","author":[{"given":"Jesper","family":"Nors","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene Hjerrild","family":"Iversen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"},{"name":"Department of Surgery, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Erichsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"},{"name":"Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Surgery, Randers Regional Hospital, Randers, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e5re Andersson","family":"Gotschalck","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"},{"name":"Department of Surgery, Horsens Regional Hospital, Horsens, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Lindbjerg","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"coi230066r1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.v68.6","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"coi230066r2","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1200\/JCO.2008.19.5362","article-title":"Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.","volume":"27","author":"Sargent","year":"2009","journal-title":"J Clin Oncol"},{"issue":"8","key":"coi230066r3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1200\/JCO.2015.63.0558","article-title":"Impact of patient factors on recurrence risk and time dependency of oxaliplatin benefit in patients with colon cancer: analysis from modern-era adjuvant studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.","volume":"34","author":"Shah","year":"2016","journal-title":"J Clin Oncol"},{"key":"coi230066r4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3109\/0284186X.2015.1131331","article-title":"Improved survival of colorectal cancer in Denmark during 2001-2012\u2014the efforts of several national initiatives.","volume":"55","author":"Iversen","year":"2016","journal-title":"Acta Oncol"},{"key":"coi230066r5","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1038\/sj.bjc.6605383","article-title":"Delay in diagnosis: the experience in Denmark.","volume":"101","author":"Olesen","year":"2009","journal-title":"Br J Cancer"},{"issue":"7","key":"coi230066r6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/DCR.0000000000000390","article-title":"Effect of multidisciplinary cancer conference on treatment plan for patients with primary rectal cancer.","volume":"58","author":"Snelgrove","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"coi230066r7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ctrv.2015.11.007","article-title":"The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature.","volume":"42","author":"Pillay","year":"2016","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"coi230066r8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.clnu.2005.02.002","article-title":"Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection.","volume":"24","author":"Fearon","year":"2005","journal-title":"Clin Nutr"},{"issue":"2","key":"coi230066r9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1200\/JCO.2009.24.1448","article-title":"Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon.","volume":"28","author":"West","year":"2010","journal-title":"J Clin Oncol"},{"issue":"10","key":"coi230066r10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/bjs.1800691019","article-title":"The mesorectum in rectal cancer surgery\u2014the clue to pelvic recurrence?","volume":"69","author":"Heald","year":"1982","journal-title":"Br J Surg"},{"issue":"4","key":"coi230066r11","first-page":"B4428","article-title":"Aspects of survival from colorectal cancer in Denmark.","volume":"59","author":"Iversen","year":"2012","journal-title":"Dan Med J"},{"key":"coi230066r12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/codi.2018.20.issue-S1","article-title":"Colon cancer surgery: pathological quality control is essential for optimal outcomes.","volume":"20","author":"West","year":"2018","journal-title":"Colorectal Dis"},{"issue":"11","key":"coi230066r13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S1470-2045(03)01248-8","article-title":"Training and quality assurance for rectal cancer: 20 years of data is enough.","volume":"4","author":"Quirke","year":"2003","journal-title":"Lancet Oncol"},{"key":"coi230066r14","doi-asserted-by":"publisher","first-page":"iv263","DOI":"10.1093\/annonc\/mdy161","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"29","author":"Glynne-Jones","year":"2018","journal-title":"Ann Oncol"},{"key":"coi230066r15","doi-asserted-by":"publisher","first-page":"vi64","DOI":"10.1093\/annonc\/mdt354","article-title":"Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"24","author":"Labianca","year":"2013","journal-title":"Ann Oncol"},{"issue":"8","key":"coi230066r16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/DCR.0000000000000410","article-title":"Practice guideline for the surveillance of patients after curative treatment of colon and rectal cancer.","volume":"58","author":"Steele","year":"2015","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"coi230066r17","first-page":"A4664","article-title":"The majority of surgical departments adhere to national Danish guidelines for surveillance after colorectal cancer surgery.","volume":"60","author":"Lykke","year":"2013","journal-title":"Dan Med J"},{"issue":"20","key":"coi230066r18","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.3748\/wjg.v23.i20.3632","article-title":"Colorectal cancer population screening programs worldwide in 2016: an update.","volume":"23","author":"Navarro","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"8","key":"coi230066r19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S2468-1253(22)00084-X","article-title":"Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study.","volume":"7","author":"Cardoso","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"coi230066r21","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"18","author":"Von Elm","year":"2007","journal-title":"Epidemiology"},{"key":"coi230066r22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2147\/CLEP","article-title":"Danish Colorectal Cancer Group Database.","volume":"8","author":"Ingeholm","year":"2016","journal-title":"Clin Epidemiol"},{"key":"coi230066r23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/CLEP","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records.","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"7","key":"coi230066r24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1403494810393562","article-title":"The Danish Cancer Registry.","volume":"39","author":"Gjerstorff","year":"2011","journal-title":"Scand J Public Health"},{"key":"coi230066r25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential.","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"2","key":"coi230066r26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/CLEP","article-title":"Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank.","volume":"2","author":"Erichsen","year":"2010","journal-title":"Clin Epidemiol"},{"issue":"7","key":"coi230066r27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System.","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"key":"coi230066r28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/CLEP","article-title":"Validity of data in the Danish Colorectal Cancer Screening Database.","volume":"9","author":"Thomsen","year":"2017","journal-title":"Clin Epidemiol"},{"issue":"7","key":"coi230066r29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish Pathology Register.","volume":"39","author":"Bjerregaard","year":"2011","journal-title":"Scand J Public Health"},{"issue":"9","key":"coi230066r30","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/ijc.v136.9","article-title":"A validated algorithm to ascertain colorectal cancer recurrence using registry resources in Denmark.","volume":"136","author":"Lash","year":"2015","journal-title":"Int J Cancer"},{"key":"coi230066r31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2147\/CLEP.S396140","article-title":"Identifying recurrences among non-metastatic colorectal cancer patients using national health data registries: validation and optimization of a registry-based algorithm in a modern Danish cohort.","volume":"15","author":"Nors","year":"2023","journal-title":"Clin Epidemiol"},{"issue":"5","key":"coi230066r32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"9","key":"coi230066r33","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9","article-title":"TNM Classification of Malignant Tumors, fifth edition (1997).","volume":"80","author":"Sobin","year":"1997","journal-title":"Cancer"},{"issue":"446","key":"coi230066r35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"coi230066r36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3748\/wjg.v20.i4.877","article-title":"Evolving treatment strategies for colorectal cancer: a critical review of current therapeutic options.","volume":"20","author":"Damin","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"7","key":"coi230066r37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1200\/OP.20.00885","article-title":"Evolution and current status of the multidisciplinary management of locally advanced rectal cancer.","volume":"17","author":"Deschner","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"3","key":"coi230066r38","first-page":"226","article-title":"The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation.","volume":"35","author":"Iv","year":"2022","journal-title":"Ann Gastroenterol"},{"issue":"1","key":"coi230066r39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clcc.2014.11.002","article-title":"A review of the evolution of systemic chemotherapy in the management of colorectal cancer.","volume":"14","author":"Gustavsson","year":"2015","journal-title":"Clin Colorectal Cancer"},{"issue":"10125","key":"coi230066r40","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"coi230066r41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2018.03.062","article-title":"Effectiveness of colorectal cancer screening in detecting earlier-stage disease\u2014a nationwide cohort study in Denmark.","volume":"155","author":"Larsen","year":"2018","journal-title":"Gastroenterology"},{"issue":"11","key":"coi230066r42","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1007\/s00384-021-03914-w","article-title":"Disease recurrence after colorectal cancer surgery in the modern era: a population-based study.","volume":"36","author":"Qaderi","year":"2021","journal-title":"Int J Colorectal Dis"},{"issue":"10","key":"coi230066r43","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"31","author":"Argil\u00e9s","year":"2020","journal-title":"Ann Oncol"},{"issue":"4","key":"coi230066r44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/codi.14503","article-title":"Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology.","volume":"21","author":"Bastiaenen","year":"2019","journal-title":"Colorectal Dis"},{"issue":"9","key":"coi230066r45","article-title":"Follow-up strategies for patients treated for non-metastatic colorectal cancer.","volume":"9","author":"Jeffery","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"coi230066r46","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1001\/jama.2018.5623","article-title":"Effect of more vs less frequent follow-up testing on overall and colorectal cancer\u2013specific mortality in patients with stage II or III colorectal cancer: the COLOFOL randomized clinical trial.","volume":"319","author":"Wille-J\u00f8rgensen","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"coi230066r47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/codi.15401","article-title":"Time for a paradigm shift in the follow-up of colorectal cancer.","volume":"23","author":"Laurberg","year":"2021","journal-title":"Colorectal Dis"},{"issue":"1","key":"coi230066r48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3748\/wjg.v25.i1.59","article-title":"Role of surveillance imaging and endoscopy in colorectal cancer follow-up: quality over quantity?","volume":"25","author":"Liu","year":"2019","journal-title":"World J Gastroenterol"},{"key":"coi230066r49","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101653","article-title":"Breast and colorectal cancer recurrence and progression captured by five U.S. population-based registries: findings from National Program of Cancer Registries patient-centered outcome research.","volume":"64","author":"Thompson","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"coi230066r50","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1002\/hec.1028","article-title":"The Danish health care system: evolution\u2014not revolution\u2014in a decentralized system.","volume":"14","author":"Pedersen","year":"2005","journal-title":"Health Econ"},{"issue":"10","key":"coi230066r51","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36666","article-title":"Incidence and survival in synchronous and metachronous liver metastases from colorectal cancer.","volume":"5","author":"Reboux","year":"2022","journal-title":"JAMA Netw Open"},{"key":"coi230066r34","volume-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017"},{"key":"coi230066r20","unstructured":"Regulation (EU) 2016\/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95\/46\/EC (General Data Protection Regulation). Accessed October 11, 2023. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32016R0679"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2812113\/jamaoncology_nors_2023_oi_230066_1704491777.82633.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T11:01:42Z","timestamp":1705575702000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2812113"}},"subtitle":["A Nationwide Danish Cohort Study"],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2023.5098","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}